Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate

By Hardling Mats   Wei Yuan   Palmqvist Lars   Swolin Birgitta   Stockelberg Dick   Gustavsson Bengt   Ekeland-Sjöberg Kerstin   Wadenvik Hans   Ricksten Anne  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 349-358

Humana Press, Inc

Access to resources Recommend Favorite

Bone marrow transplantation for children with acute myelogenous leukaemia in the first complete remission

By Matsuyama T.   Horibe K.   Kato K.   Kojima S.S.  

European Journal of Cancer, Vol. 36, Iss. 3, 2000-02 ,pp. : 368-375

Elsevier

Access to resources Recommend Favorite

The Detection of Micrometastases in the Peripheral Blood and Bone Marrow of Patients with Breast Cancer Using Immunohistochemistry and Reverse Transcriptase Polymerase Chain Reaction for Keratin 19

By Schoenfeld A.   Kruger K.H.   Gomm J.   Sinnett H.D.   Gazet J.-C.   Sacks N.   Bender H.G.   Luqmani Y.   Coombes R.C.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 854-861

Elsevier

Access to resources Recommend Favorite

The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia

By Perego R.A.   Costantini  

European Journal of Cancer, Vol. 36, Iss. 11, 2000-07 ,pp. : 1395-1401

Elsevier

Access to resources Recommend Favorite

Trichosanthin down-regulated p210^Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562

By Zhang Kunzhong   Xu Jianhua   Huang Xiuwang   Wu Lixian   Wen Caixia   Hu Yingying   Su Yu   Chen Yuanzhong   Zhang Zhiqiang  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 581-587

Springer Publishing Company

Access to resources Recommend Favorite